Cell counts in recipient mice 6 weeks after bone marrow transplantation
Donor/recipient . | Leukocytes in blood, ×109/L . | BM, ×10-6 . | Ter119+ MNCs in BM, ×10-6 . | Spleen, ×10-7 . | Thymus, ×10-7 . |
---|---|---|---|---|---|
WT (CD45.2+)/WT (CD45.1+) | 10.2 ± 2.0 | 20.3 ± 4.8 | 7.2 ± 0.6 | 11.1 ± 1.6 | 4.6 ± 1.0 |
gp130flox/flox/TCre (CD45.2+)/WT (CD45.1+) | 7.8 ± 1.8 | 26.7 ± 0.4 | 9.1 ± 1.7 | 9.8 ± 2.3 | 5.0 ± 0.5 |
WT (CD45.1+)/WT (CD45.2+) | 7.4 ± 1.4 | 30.3 ± 6.1 | 10.8 ± 1.7 | 10.3 ± 1.4 | 4.3 ± 0.3 |
WT (CD45.1+)/gp130flox/flox/TCre (CD45.2+) | 15.8 ± 4.1* | 15.2 ± 1.2* | 3.6 ± 1.0† | 23.0 ± 2.8* | 1.7 ± 0.2* |
Donor/recipient . | Leukocytes in blood, ×109/L . | BM, ×10-6 . | Ter119+ MNCs in BM, ×10-6 . | Spleen, ×10-7 . | Thymus, ×10-7 . |
---|---|---|---|---|---|
WT (CD45.2+)/WT (CD45.1+) | 10.2 ± 2.0 | 20.3 ± 4.8 | 7.2 ± 0.6 | 11.1 ± 1.6 | 4.6 ± 1.0 |
gp130flox/flox/TCre (CD45.2+)/WT (CD45.1+) | 7.8 ± 1.8 | 26.7 ± 0.4 | 9.1 ± 1.7 | 9.8 ± 2.3 | 5.0 ± 0.5 |
WT (CD45.1+)/WT (CD45.2+) | 7.4 ± 1.4 | 30.3 ± 6.1 | 10.8 ± 1.7 | 10.3 ± 1.4 | 4.3 ± 0.3 |
WT (CD45.1+)/gp130flox/flox/TCre (CD45.2+) | 15.8 ± 4.1* | 15.2 ± 1.2* | 3.6 ± 1.0† | 23.0 ± 2.8* | 1.7 ± 0.2* |